Nippon India Pharma Fund - Direct Plan - Growth Plan
Add To Comparepreviously known as Reliance Pharma Dir Gr until
NAV on May 17, 2024
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
7,133 cr
Turnover Ratio
18.67%
Expense Ratio
0.92%
Exit Load
1.00%
if redeemed within
Returns
- 1M: 2.55%
- 1Y: 54.89%
- 3M: 0.34%
- 3Y: 16.00%
- 6M: 18.59%
- 5Y: 26.38%
Best Arbitrage Fund Funds
NAME | LATEST NAV |
RETURNS 1y |
FUND ASSETS |
Expense RATIO |
RISK | |
14.042 | — | 279 cr | 0.68% | - |
Best Sector Healthcare Funds
NAME | LATEST NAV |
RETURNS 1y |
FUND ASSETS |
Expense RATIO |
RISK | |
32.860 | 58.21% | 3,835 cr | 1.04% | - | ||
29.094 | 55.80% | 894 cr | 0.83% | - | ||
478.689 | 54.89% | 7,133 cr | 0.92% | - | ||
393.163 | 53.19% | 2,667 cr | 0.95% | - |
Other plans of Nippon India Pharma